These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15574559)

  • 41. ICVTS on-line discussion A Plateletpheresis or aprotinin, which is the key element?
    Kan CD
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):622; discussion 622. PubMed ID: 17884856
    [No Abstract]   [Full Text] [Related]  

  • 42. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
    Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
    Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraoperative monitoring and postoperative reevaluation of hemostasis in orthotopic liver transplantation.
    Azad SC; Kratzer MA; Groh J; Welte M; Haller M; Pratschke E
    Semin Thromb Hemost; 1993; 19(3):233-7. PubMed ID: 8362253
    [No Abstract]   [Full Text] [Related]  

  • 47. The use of aprotinin in Norway.
    Bjella L; Greiff G; Pleym H; Stenseth R; Wahba A
    Acta Anaesthesiol Scand; 2007 Feb; 51(2):261; author reply 261. PubMed ID: 17261150
    [No Abstract]   [Full Text] [Related]  

  • 48. Aprotinin in orthotopic liver transplantation.
    Bechstein WO; Riess H; Blumhardt G; Himmelreich G; Jochum M; Gerlach H; Rossaint R; Keck H; Neuhaus P
    Semin Thromb Hemost; 1993; 19(3):262-7. PubMed ID: 7689751
    [No Abstract]   [Full Text] [Related]  

  • 49. Aprotinin: twenty-five years of claim and counterclaim.
    Westaby S
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):487-91. PubMed ID: 18329457
    [No Abstract]   [Full Text] [Related]  

  • 50. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
    [No Abstract]   [Full Text] [Related]  

  • 51. Toward reducing perioperative transfusions.
    Joyce JA
    AANA J; 2008 Apr; 76(2):131-7. PubMed ID: 18478819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Aprotinine: safe use in surgical practice].
    Dement'eva II; Charnaia MA; Morozov IuA
    Anesteziol Reanimatol; 2007; (2):69-71. PubMed ID: 17564008
    [No Abstract]   [Full Text] [Related]  

  • 53. Aprotinin reduces blood loss during spinal surgery in children.
    Cole JW; Murray DJ; Snider RJ; Bassett GS; Bridwell KH; Lenke LG
    Spine (Phila Pa 1976); 2003 Nov; 28(21):2482-5. PubMed ID: 14595168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Aprotinin (Antilysin Spofa)--its effect on decreasing hemorrhage in the postoperative period in hip arthroplasty].
    Cvachovec K; Sechovská H; Berousek J; Popelka S; Hladíková M
    Acta Chir Orthop Traumatol Cech; 2001; 68(5):311-4. PubMed ID: 11759474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations.
    Massicotte L; Lenis S; Thibeault L; Sassine MP; Seal RF; Roy A
    Liver Transpl; 2006 Jan; 12(1):117-23. PubMed ID: 16382461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is aprotinin safe when used in the context of profound hypothermia and circulatory arrest? A literary review.
    Hornick P; Taylor KM
    J Heart Valve Dis; 1995 Nov; 4(6):669-73. PubMed ID: 8611984
    [No Abstract]   [Full Text] [Related]  

  • 57. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 58. [The rational use of aprotinin during orthotopic liver transplantation].
    Lagneau F; Kavafyan J; Marty J
    Ann Fr Anesth Reanim; 2001 Apr; 20(4):421-2. PubMed ID: 11392257
    [No Abstract]   [Full Text] [Related]  

  • 59. Aprotinin in liver transplantation.
    Porte RJ; Molenaar IQ
    Hepatology; 1998 Apr; 27(4):1169-71. PubMed ID: 9537463
    [No Abstract]   [Full Text] [Related]  

  • 60. [Anaesthesiological management in orthotopic liver transplantation -- results of a survey].
    Pietsch UC; Schaffranietz L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Jan; 41(1):21-6. PubMed ID: 16440255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.